8,654 results match your criteria Catheterization and Cardiovascular Interventions[Journal]


Index of microvascular resistance to assess the effect of rosuvastatin on microvascular function in women with chest pain and no obstructive coronary artery disease: A double-blind randomized study.

Catheter Cardiovasc Interv 2019 Feb 21. Epub 2019 Feb 21.

Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.

Introduction: Many women undergoing coronary angiography for chest pain have no or only minimal coronary artery disease (CAD). However, despite the lack of obstructive CAD, they still have an increased risk of major adverse cardiovascular events. Pleiotropic effects of statins may influence microvascular function, but if statins improve microvascular function in unselected chest pain patients is not well studied. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28157DOI Listing
February 2019

Catheter based treatments for fibrosing mediastinitis.

Catheter Cardiovasc Interv 2019 Feb 21. Epub 2019 Feb 21.

Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.

Fibrosing mediastinitis is a rare, often debilitating and potentially lethal disease characterized by an exuberant fibroinflammatory response within the mediastinum. Patients typically present with insidious symptoms related to compression of adjacent structures including the esophagus, heart, airways, and cardiac vessels. Fibrosing mediastinitis is most often triggered by Histoplasmosis infection; however, antifungal and anti-inflammatory therapies are largely ineffective. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28152DOI Listing
February 2019

Letter to the editor regarding the original article by Gianluca Rigatelli et al. presenting novel stenting technique for complex coronary bifurcation.

Catheter Cardiovasc Interv 2019 Feb 21. Epub 2019 Feb 21.

Department of Cardiac Intervention, Fortis Hospital Anandapur, Kolkata, West Bengal, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28153DOI Listing
February 2019

Transapical percutaneous closure of rapidly expanding post-surgical left ventricular outflow tract pseudoaneurysm.

Catheter Cardiovasc Interv 2019 Feb 21. Epub 2019 Feb 21.

Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.

Left ventricular pseudoaneurysm is an infrequent but potentially fatal complication following cardiac surgery, with spontaneous rupture being the most feared result. Moreover, surgical repair is associated with significant morbidity and mortality. We present a successful transapical percutaneous closure of a post-surgical rapidly expanding left ventricular outflow tract (LVOT) pseudoaneurysm utilizing Amplatz Vascular Plug-II (AVP-II) (St. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28154DOI Listing
February 2019

Trends in complete heart block after transcatheter aortic valve replacement: A population based analysis.

Catheter Cardiovasc Interv 2019 Feb 21. Epub 2019 Feb 21.

Division of Cardiology, Rush University Medical Center, Chicago, Illinois.

Objectives: To define the national rate of complete heart block (CHB) after transcatheter aortic valve replacement (TAVR) and its impact on procedural mortality, overall cost, and length of hospital stay.

Background: CHB leading to permanent pacemaker (PPM) implantation is one of the most common complications post TAVR. National data on the temporal trend of CHB post TAVR are lacking. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28156DOI Listing
February 2019

Hemodynamic and clinical response to transseptal mitral valve-in-valve and valve-in-ring.

Catheter Cardiovasc Interv 2019 Feb 21. Epub 2019 Feb 21.

Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.

Objective: To understand the clinical and hemodynamic response of patients with stenotic versus regurgitant prosthetic mitral valve degeneration to transseptal transcatheter mitral valve-in-ring/-valve replacement (TMVR).

Background: Patients with prosthetic mitral valve repair/replacement failure frequently present high-risk surgical challenges. TMVR has been employed as an alternative to surgery. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28149DOI Listing
February 2019

Optical coherence tomography and intravascular ultrasound assessment of the anatomic size and wall thickness of a muscle bridge segment.

Catheter Cardiovasc Interv 2019 Feb 21. Epub 2019 Feb 21.

Department of Cardiology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.

Objective: To use optical coherence tomography (OCT) and intravascular ultrasound (IVUS) in assessing myocardial bridging (MB) vessel size and wall thickness.

Background: During stent implantation, MB is associated with complications, especially perforation.

Methods: OCT and IVUS were performed in 56 patients with typical angiographic "milking" from November 2016 to May 2017. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28094DOI Listing
February 2019

Outcomes in patients with peripheral vascular disease following percutaneous coronary intervention.

Catheter Cardiovasc Interv 2019 Feb 21. Epub 2019 Feb 21.

Department of Cardiology, Box Hill Hospital, Melbourne, Victoria, Australia.

Objectives: To evaluate the clinical characteristics and outcomes of patients with peripheral vascular disease (PVD) undergoing percutaneous coronary intervention (PCI) in a contemporary setting, and to determine whether use of drug-eluting stents (DESs) improves outcomes.

Background: PVD was an independent risk factor for adverse outcomes following PCI in the bare-metal stent (BMS) era. It is not known whether outcomes in these patients have improved with advances in interventional techniques and stent technology, as they have for the general population. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28145DOI Listing
February 2019

Hemodynamic characterization of aortic stenosis states.

Catheter Cardiovasc Interv 2019 Feb 21. Epub 2019 Feb 21.

Department of Medicine, Laval University, Quebec City, QC, Canada.

Aortic stenosis (AS) has become an increasingly prevalent clinical condition, as a result of the "greying of the population", the widespread application of sophisticated diagnostic tools including non-invasive imaging and invasive techniques, and the advent of minimally invasive surgical and percutaneous valve therapies. The diagnosis of severe AS traditionally has relied on the assessment of the mean transvalvular gradient (ΔP ) and aortic valve area (AVA) by either echocardiography or catheterization. However, other hemodynamic variables as flow, pressure recovery, and jet eccentricity also play a major role in determining the final hemodynamic state of AS. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28146DOI Listing
February 2019

Novel predictors of late lumen enlargement in distal reference segments after successful recanalization of coronary chronic total occlusion.

Catheter Cardiovasc Interv 2019 Feb 21. Epub 2019 Feb 21.

Department of Cardiovascular Medicine, Tokushima Red Cross Hospital, Komatsushima, Japan.

Objectives: Although successful recanalization of coronary chronic total occlusion (CTO) can induce subsequent positive vascular remodeling in the distal segment, the predictors are not fully understood. The aim of this study was to investigate the extent and predictors related to luminal gain after successful CTO recanalization.

Methods: A total of 134 patients who underwent intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) for CTO and follow-up angiography were included. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28143DOI Listing
February 2019

Classification scheme for ductal morphology in cyanotic patients with ductal dependent pulmonary blood flow and association with outcomes of patent ductus arteriosus stenting.

Catheter Cardiovasc Interv 2019 Feb 21. Epub 2019 Feb 21.

Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia.

Objectives: To devise a classification scheme for ductal morphology in patients with ductal dependent pulmonary blood flow (PBF) that can be used to assess outcomes.

Background: The impact of ductal morphology on outcomes following patent ductus arteriosus (PDA) stenting is not well defined.

Methods: Patients <1 year of age who underwent PDA stenting for ductal dependent PBF at the four centers comprising the Congenital Catheterization Research Collaborative (CCRC) were included. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28125DOI Listing
February 2019

Transcatheter aortic valve in valve implantation with bioprosthetic valve fracture.

Catheter Cardiovasc Interv 2019 Feb 21. Epub 2019 Feb 21.

Departments of Cardiology and Cardiothoracic Surgery, JFK Medical Center, Atlantis, Florida.

Valve-in-valve transcatheter aortic valve replacement (VIV TAVR) has emerged as a preferable option for high surgical risk patients requiring redo aortic valve replacement. However, VIV TAVR may restrict flow, especially in small native aortic valves. To remedy this, bioprosthetic valve fracture has been utilized to increase the effective orifice area and improve hemodynamics. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28113DOI Listing
February 2019

Treatment of rotablation-induced ostial left circumflex perforation by papyrus covered stent and its fenestration to recover the left anterior descending artery during CHIP procedure.

Catheter Cardiovasc Interv 2019 Feb 21. Epub 2019 Feb 21.

Heart and Lung Institute, The Prince Charles Hospital, Chermside, Queensland, Australia.

Coronary artery perforation is a rare complication of percutaneous coronary intervention (PCI). Covered stents have been successfully used in these situations. We report a case of ostial left circumflex (LCx) artery perforation during rotablation PCI of left main coronary artery (LMCA) and LCx artery. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28114DOI Listing
February 2019

Left ventricular geometry predicts optimal response to percutaneous mitral repair via MitraClip: Integrated assessment by two- and three-dimensional echocardiography.

Catheter Cardiovasc Interv 2019 Feb 21. Epub 2019 Feb 21.

Greenberg Cardiology Division, Weill Cornell Medicine, New York, New York.

Objectives: To assess impact of left ventricular (LV) chamber remodeling on MitraClip (MClp) response.

Background: MitraClip is the sole percutaneous therapy approved for mitral regurgitation (MR) but response varies. LV dilation affects mitral coaptation; determinants of MClp response are uncertain. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28147DOI Listing
February 2019

Temporal trends of survival and utilization of mechanical circulatory support devices in patients with in-hospital cardiac arrest secondary to ventricular tachycardia/ventricular fibrillation.

Catheter Cardiovasc Interv 2019 Feb 21. Epub 2019 Feb 21.

Division of Cardiovascular diseases, Department of Medicine, University of Miami-Miller School of Medicine, Miami, Florida.

Background: Pulseless ventricular tachycardia/ventricular fibrillation (VT/VF) is the initial rhythm in a third of in-hospital cardiac arrest patients. Mechanical circulatory support (MCS) device use remains poorly understood in this population.

Methods: We conducted an observational analysis of temporal trends in the utilization of MCS in VT/VF IHCA between January 2008 and December 2014 utilizing the Nationwide Inpatient Sample (NIS) database. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28138DOI Listing
February 2019

Percutaneous treatment of mitral regurgitation in patients with impaired ventricular function: Impact of intracardiac electronic devices (from the German Transcatheter Mitral Valve Interventions Registry).

Catheter Cardiovasc Interv 2019 Feb 21. Epub 2019 Feb 21.

Deapartment of Cardiology and Clinical Cardiovascular Research Unit, Vivantes Klinikum im Friedrichshain und Am Urban, Berlin, Germany and Rostock University Medical Center, Rostock, Germany.

Objectives: To identify prevalence/impact of previous implantation of cardiac electronic devices (CEDs), such as cardioverter defibrillator (ICD) and cardiac resynchronization (CRT), in a group of MitraClip (MC) candidates with LVEF < 30%.

Background: MC therapy is nowadays often considered in patients with depressed left ventricular ejection fraction (LVEF%) and symptomatic severe secondary MR.

Methods: Data from the German Transcatheter Mitral Valve Interventions (TRAMIs) registry were analyzed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28127DOI Listing
February 2019

Hydraulic stimulation of carotid artery baroreceptors as a likely cause of transient asystolic cardiac arrest during diagnostic angiography or surgical endarterectomy.

Catheter Cardiovasc Interv 2019 Feb 21. Epub 2019 Feb 21.

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota.

We describe two patients-both who underwent general anesthesia-in whom we theorize that hydraulic pressure on carotid artery baroreceptors resulted in transient asystolic cardiac arrest (TACA) during diagnostic or therapeutic procedures. Patient #1 was a 58-year-old female who experienced TACA in response to rapid injection of radiocontrast material into the carotid artery during diagnostic cerebral angiography. Her history was remarkable for aneurysmal subarachnoid hemorrhage at least 13 hr prior to angiography, radiographic evidence of intracranial hypertension, and baseline bradycardia, collectively suggestive of increases in baseline vagal tone. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28126DOI Listing
February 2019

Clinical outcomes of the Lotus Valve in patients with bicuspid aortic valve stenosis: An analysis from the RESPOND study.

Catheter Cardiovasc Interv 2019 Feb 17. Epub 2019 Feb 17.

Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, CE, Rotterdam, The Netherlands.

Aims: Patients with bicuspid valves represent a challenging anatomical subgroup for transcatheter aortic valve implantation (TAVI). This analysis evaluated the clinical outcomes of the fully repositionable and retrievable Lotus Valve System in patients with bicuspid aortic valves enrolled in the RESPOND post-market registry.

Methods And Results: The prospective, open-label RESPOND study enrolled 1,014 patients at 41 centers in Europe, New Zealand, and Latin America, 31 (3. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28120DOI Listing
February 2019

Transfemoral transcatheter aortic valve implantation after aortic valve repair with HAART 300 device.

Catheter Cardiovasc Interv 2019 Feb 17. Epub 2019 Feb 17.

Department of Cardiovascular Surgery, Sana-Herzzentrum Cottbus, Cottbus, Germany.

We report the first successful case, to our knowledge, of CoreValve Evolut R (Medtronic, Minneapolis, MN) implantation into a failed HAART 300 aortic annuloplasty device (BioStable Science & Engineering, TX). An 81-year-old man presented with severe symptomatic aortic regurgitation secondary to failure of the 21 mm HAART 300 device, which had been implanted 45 days previously. Transthoracic echocardiography (TTE) revealed grade 3 aortic regurgitation with central jet, without aortic valve stenosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28129DOI Listing
February 2019

Sirolimus-eluting BiOSS LIM dedicated bifurcation stent in the treatment of unprotected distal left main stenosis.

Catheter Cardiovasc Interv 2019 Feb 17. Epub 2019 Feb 17.

Department of Mental Health and Preventive Medicine, Second University of Naples, Naples, Italy.

Background: Proximal optimization technique (POT) has been proposed to adapt the conventional drug-eluting stent (DES) with the fractal anatomy of the bifurcation. However, only few DES are labeled for post-expansion beyond 5.0 mm. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ccd.28132
Publisher Site
http://dx.doi.org/10.1002/ccd.28132DOI Listing
February 2019
1 Read

Efficacy of the SEPARPROCATH® radiation drape to reduce radiation exposure during cardiac catheterization: A pilot comparative study.

Catheter Cardiovasc Interv 2019 Feb 17. Epub 2019 Feb 17.

Department of Cardiology, University and Hospital of Fribourg, Fribourg, Switzerland.

Background: Interventional cardiologists are exposed to radiation-induced diseases, partly due to patient's scatter radiation.

Objectives: We sought to compare the radiation exposure (RE) of the cardiac catheterization room staff using SEPARPROCATH®, a novel radio-protective drape versus standard shielding equipment.

Methods: This was a two-step prospective, randomized pilot trial: first, in experimental conditions using a phantom model, and second, during cardiac catheterization. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28130DOI Listing
February 2019

Comparison of myocardial microcirculatory perfusion after catheter-administered intracoronary thrombolysis with anisodamine versus standard thrombus aspiration in patients with ST-elevation myocardial infarction.

Catheter Cardiovasc Interv 2019 Feb 17. Epub 2019 Feb 17.

Department of Cardiology, Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

Objective: To evaluate efficacy, safety and feasibility of targeted intracoronary injection using pro-urokinase combined with anisodamine (TCA) versus thrombus aspiration (TA) in ST-elevation myocardial infarction (STEMI) patients with high thrombus loads.

Background: The best method of avoiding thrombus detachment and stroke in PCI patients with high thrombus loads has not yet been established.

Methods: STEMI patients receiving coronary artery angiography or percutaneous coronary intervention (CAG/PCI) with thrombus grade ≥ 3 from January 1, 2017 to June 30, 2018 were randomly assigned to targeted intracoronary thrombolysis (pro-urokinase and anisodamine via catheter (TCA) group), or the TA group which followed the standard thrombus aspiration procedure. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28112DOI Listing
February 2019

Long-term follow-up of covered stent implantation for various coronary artery diseases.

Catheter Cardiovasc Interv 2019 Feb 17. Epub 2019 Feb 17.

Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy.

Objectives: The aims of this study were to evaluate the long-term clinical outcomes after coronary covered stent (CS) implantation and to compare the results according to the indications.

Background: To date, data on the long-term follow-up of coronary CS are limited, and no studies have been conducted to compare outcomes on the basis of specific lesions treated.

Methods: A total of 190 consecutive patients (212 lesions) implanted with CS and surviving until discharge between May 1997 and February 2017 were enrolled in this retrospective study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28117DOI Listing
February 2019

The predictors of complications in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

Catheter Cardiovasc Interv 2019 Feb 17. Epub 2019 Feb 17.

Division of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.

Objectives: The aims of this study were to (1) evaluate risk factors of complications of balloon pulmonary angioplasty (BPA) and (2) assess the mechanism of the complications.

Background: BPA represents a promising treatment option in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH). However, the complication ratio differs across reports, and the causes remain controversial. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28133DOI Listing
February 2019

Case report: Atrioventricular block after transcatheter atrial septal closure using the Figulla® Flex II ASD occluder.

Catheter Cardiovasc Interv 2019 Feb 17. Epub 2019 Feb 17.

Department of Paediatric Cardiology, Japan Community Health Organization Chukyo Hospital, Nagoya, Japan.

We report a 7-year-old male patient who developed severe atrioventricular block after transcatheter closure of the atrial septal defect with an Occlutech Figulla® Flex II ASD occluder (FSO). He had a small aortic rim and the defect measuring 22.3 mm by balloon sizing. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28148DOI Listing
February 2019

No Option? Maybe just a matter of time, as in No Option for now?

Authors:
Samuel Butman

Catheter Cardiovasc Interv 2019 Feb;93(3):E187-E188

CV Research, Verde Valley Medical Center, Cottonwood, Arizona.

The No Option coronary patient may have options after all. Rethinking the state of the No Option patient at follow-up may be more fruitful than expected. Reviewing videos by more experienced interventionalists AND surgeons may also yield more options. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28005DOI Listing
February 2019

Dual antithrombotic therapy in PCI: Potential harm in routine adoption.

Catheter Cardiovasc Interv 2019 Feb;93(3):E185-E186

Division of Cardiology, Rhode Island Hospital, Warren Alpert Medical School at Brown University, Providence, Rhode Island.

Randomized clinical trials support the use of dual antithrombotic therapy (DAT) in PCI patients but outcomes in clinical practice are unclear. In this observational study of patients at high risk for thromboembolism and bleeding, routine use of a P2Y12 inhibitor alone compared with DAPT with OAC was associated with a significantly higher risk of ischemic events without a lower risk of bleeding. Future randomized trials and observational analyses of large registries are needed to select the ideal patient population for DAT. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.27999DOI Listing
February 2019

PCI on a tear: Not all perforations need coverage.

Catheter Cardiovasc Interv 2019 Feb;93(3):426-427

Department of Cardiology, St. Luke's Medical Center, University of Arizona College of Medicine, Phoenix, Arizona.

Coronary perforations are a potentially lethal complication of PCI requiring prompt treatment. The study by Rosseel et al demonstrates no difference in 5-year outcomes in patients with large coronary perforations treated with and without covered stents. Covered stents are effective in treating coronary perforations and are invaluable in the cardiac catheterization lab. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28137DOI Listing
February 2019

I do not want to go to the hospital again.

Catheter Cardiovasc Interv 2019 Feb;93(3):380-381

The Heart and Vascular Center of Northern Arizona, Verde Valley Medical Center, Cottonwood, Arizona.

Readmission after myocardial infarction is not uncommon. The likely readmission patient is by and large predictable. Coronary interventions appear to reduce the rate of readmissions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28140DOI Listing
February 2019
1 Read

Covered stents: A 25-year odyssey.

Catheter Cardiovasc Interv 2019 Feb;93(3):E189-E190

St. Luke's Medical Center, University of Arizona College of Medicine, Phoenix, Arizona.

The concept of the PTFE-covered stent was introduced 25 years ago in the treatment of an aneurysmal vein graft. The study by Pavani et al. represents the largest cohort of patients treated with covered stents for Ellis type 3 perforations. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28006DOI Listing
February 2019

Percutaneous PDA closure with Amplatzer AVP ll and ADO ll AS devices.

Authors:
Victor Sam Lucas

Catheter Cardiovasc Interv 2019 Feb;93(3):E197

Pediatric Cardiology, Ochsner Hospital for Children, Ochsner Health System, New Orleans, Louisiana.

AVP ll and ADO ll AS devices are effective and safe for percutaneous PDA closure. Residual shunt and serious complications are uncommon Mild LPA stenosis and device embolization are the most frequent complications reported. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28002DOI Listing
February 2019

Positioning of self-expanding transcatheter valve prostheses.

Catheter Cardiovasc Interv 2019 Feb;93(3):530-531

Icahn School of Medicine at Mount Sinai, Cardiovascular Institute, Mount Sinai Hospital, New York, New York.

The anatomic interplay between aortic valve, ascending aorta, left ventricular outflow tract and peripheral vasculature play a major role in determining device related outcomes in transcatheter aortic valve replacement. Factors such as the alignment angle (prosthesis-ascending aorta), pre-dilatation, operating team experience and chronic kidney disease may play a role in valve displacement. Careful analysis of all imaging modalities while sizing and selecting a valve type, and attention to newer deployment techniques may improve outcomes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28134DOI Listing
February 2019

Percutaneous pulmonary valve implantation: It's not like the aortic valve.

Catheter Cardiovasc Interv 2019 Feb;93(3):464-465

Department of Cardiology, Texas Heart Institute, Houston, Texas.

The Edwards Sapien S3 demonstrated clinical and technical feasibility in this cohort undergoing percutaneous pulmonary valve implantation. Traversing the tricuspid apparatus with an unsheathed delivery system continues to pose a risk for tricuspid valve injury. Future design innovations need to accommodate for large outflow tracts without adjacent aortic or coronary compression and allow for safe device delivery with minimal trauma to the tricuspid apparatus. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28141DOI Listing
February 2019

Roadmap for the radial: Should we stop for directions?

Catheter Cardiovasc Interv 2019 Feb;93(3):E195-E196

MS Hershey Medical Center, College of Medicine, Heart & Vascular Institute, Penn State University, Hershey, PA.

Regimented use of radial artery angiography prior to ST-segment myocardial infarction (STEMI) intervention may improve complication rates and can be associated with improved procedural success, procedural time, and reduction in access-site bleeding. Routine radial artery angiography may improve procedural quality without increase in procedural time or contrast use. Regardless of whether universal or selective radial angiography is best practice, angiography is an important tool to use for efficient radial access. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28058DOI Listing
February 2019
1 Read

Impella support for chronic total occlusions angioplasty: A good start.

Catheter Cardiovasc Interv 2019 Feb;93(3):E191-E192

Department of Interventional Cardiology and Endovascular Therapeutics, Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.

There is limited data regarding percutaneous ventricular support in chronic total occlusion angioplasty in terms of population, procedure, and outcomes. This is the largest report to date showing promising results in terms of technical and procedural success in this highly comorbid population. This study encourages more research in the area and its use in large volume and experienced centers. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28007DOI Listing
February 2019

A catheter-based bariatric procedure: Wishful thinking or an intriguing concept.

Authors:
Ian C Gilchrist

Catheter Cardiovasc Interv 2019 Feb;93(3):371-372

MS Hershey Medical Center, College of Medicine, Heart and Vascular Institute, Penn State University, Hershey, Pennsylvania.

Left gastric artery embolization acutely lowers ghrelin levels and is associated with modest weight loss sustainable for 1 year in morbidly obese patients. The procedure is relative quick, free of access complications when done via the radial artery, but long-term sequelae and the durability of ischemic injury to the fundus of the stomach is uncertain. Present reports provide pilot and proof-of-concept data that should fashion further study, but application to routine practice today is premature. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28139DOI Listing
February 2019

CAD strategy in the TAVR era.

Catheter Cardiovasc Interv 2019 Feb;93(3):553-554

Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois.

The optimal revascularization strategy for CAD in the TAVR population is not well-defined and decisions about which patients require PCI have been largely operator dependent or based on SYNTAX score. In a TAVR population, complete revascularization does not improve short or long term mortality, but is associated with decreased acute myocardial infarction and revascularization, when compared with incomplete revascularization. Future prospective studies should evaluate revascularization strategies in TAVR patients, including considering functional lesion assessment with fractional flow reserve, especially as TAVR indications are likely to soon expand to a younger and healthier cohort. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28135DOI Listing
February 2019
1 Read

Branch pulmonary artery stenting in children by using premounted stents: Can we benefit from slenderization?

Catheter Cardiovasc Interv 2019 Feb;93(3):E198-E199

Department of Cardiology, Texas Heart Institute, Houston, Texas.

Children with branch pulmonary artery stenosis represent a challenging cohort for stenting Premounted stent implantation provides immediate obstruction relief and hemodynamic improvement in infants Planned stent intervention is required to account for somatic growth and next stage palliation in children Continued slenderization of adult coronary and peripheral interventions, stent technology, and delivery systems may allow for more durable solutions in light of patient size. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28010DOI Listing
February 2019

HAS-BLED for predicting transfemoral transcatheter aortic valve replacement outcomes: Enough to tamponade the problem?

Catheter Cardiovasc Interv 2019 Feb;93(3):E202-E203

Division of Cardiology, Department of Medicine, Regional Heart Center, University of Washington, Seattle, Washington.

As indications for TAVR expand, there is a need for predictive models of procedural complications. Application of the HAS-BLED score demonstrated patient comorbidities that contribute to increased bleeding events and mortality. Further adequately powered studies will be needed to validate the HAS-BLED score for use in the TAVR population or further elucidate important risk factor to incorporate into future predictive risk models. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28004DOI Listing
February 2019

The Aortix device: Support in a tube.

Catheter Cardiovasc Interv 2019 Feb;93(3):434-435

Interventional Cardiology, Lankenau Heart Institute, Wynnewood, Pennsylvania.

The use of percutaneous mechanical support devices is becoming more embedded within the therapeutic armamentarium for patients presenting with decompensated heart failure, cardiogenic shock, and patients undergoing high risk PCI. The Aortix device offers a new approach to percutaneous support that appears to be safe to implement and overcomes some of the drawbacks of the extant devices. Further investigation remains warranted to evaluate its ultimate utility and place among the approach to the patient in need of circulatory support. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28136DOI Listing
February 2019

Treating saphenous vein graft lesions: Drug-eluting stents are not the answer!

Catheter Cardiovasc Interv 2019 Feb;93(3):E193-E194

Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota.

Saphenous vein graft (SVG) percutaneous coronary intervention carries high rates of acute (no reflow and periprocedural myocardial infarction) and long-term (restenosis and re-occlusion) complications. Long-term follow-up from the two largest trials of drug-eluting vs. bare metal stents in SVG lesions (The Drug-Eluting Stents vs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28011DOI Listing
February 2019
1 Read

Every TAVR deserves a cardiac implantable electronic device specialist.

Catheter Cardiovasc Interv 2019 Feb;93(3):E200-E201

Long Beach Veteran's Administration Medical Center, Long Beach, California.

TAVR patients given pacemakers operating in mandatory DDD mode had more ventricular pacing, heart failure hospitalization, and mortality compared with AAI-DDD or VVI modes. AV conduction disturbances are often transient after TAVR. Minimizing ventricular pacing where possible avoids the risk of pacemaker-induced cardiomyopathy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28000DOI Listing
February 2019
1 Read

What do renal stents and parachutes have in common?

Catheter Cardiovasc Interv 2019 Feb 14. Epub 2019 Feb 14.

Department of Medicine and Cardiology, Ochsner Clinical School, University of Queensland, AU, Ochsner Medical Center, New Orleans, Louisiana.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28151DOI Listing
February 2019
1 Read

Drug-coated balloon versus uncoated percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery: 2-year results of the MDT-2113 SFA Japan randomized trial.

Catheter Cardiovasc Interv 2019 Feb 12. Epub 2019 Feb 12.

Fukuoka Sanno Hospital, Fukuoka, Japan.

Objectives: To assess the longer-term safety and efficacy of the IN.PACT Admiral (MDT-2113) drug-coated balloon (DCB) for the treatment of de novo and non-stented restenotic lesions in the superficial femoral and/or proximal popliteal arteries versus uncoated percutaneous transluminal angioplasty (PTA) in a Japanese cohort.

Background: Although DCBs are the newest endovascular strategy for patients with peripheral artery disease presenting with femoropopliteal lesions, there remains a paucity of results in non-Caucasian populations. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28048DOI Listing
February 2019

Temporary balloon occlusion of atrial septal defects in suspected or documented left ventricular diastolic dysfunction: Hemodynamic and clinical findings.

Catheter Cardiovasc Interv 2019 Feb 12. Epub 2019 Feb 12.

Department of Pediatric and Adolescent Medicine/Division of Pediatric Cardiology, Mayo Clinic, Rochester, Minnesota.

Objective: To review our experience with balloon testing prior to atrial septal defect (ASD) closure in adults with left ventricular (LV) diastolic dysfunction.

Background: ASD closure in patients with LV diastolic dysfunction may precipitate LV failure. Temporary ASD occlusion has been used in this scenario but data are limited. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28150DOI Listing
February 2019
2 Reads
2.107 Impact Factor

Stent-retriever thrombectomy in the treatment of infants with acute thrombosis of the superior vena cava and innominate vein.

Catheter Cardiovasc Interv 2019 Feb 9. Epub 2019 Feb 9.

Department of Pediatric Cardiology, University Hospital Tuebingen, Tuebingen, Germany.

Objectives: To describe the efficacy and safety of stent-retriever thrombectomy in infants with thrombosis of the superior vena cava (SVC) and innominate vein.

Background: Thrombosis of the SVC and of the innominate vein is a potentially life threatening complication in infants during intensive care treatment following major surgical procedures. To avoid reoperations, we evaluated interventional revascularization by stent-retriever thrombectomy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28142DOI Listing
February 2019
1 Read

Comparison of neointimal coverage between durable-polymer everolimus-eluting stents and bioresorbable-polymer everolimus-eluting stents 1 year after implantation using high-resolution coronary angioscopy.

Catheter Cardiovasc Interv 2019 Feb 9. Epub 2019 Feb 9.

Department of Cardiology, Nishinomiya Municipal Central Hospital, Nishinomiya, Hyogo, Japan.

Objectives: We aimed to compare the coronary angioscopic appearance of neointimal coverage (NIC) over durable-polymer everolimus-eluting stents (XIENCE-EES) and bioresorbable-polymer everolimus-eluting stents (SYNERGY-EES) 1 year after implantation.

Background: XIENCE-EES and SYNERGY-EES have been developed to prevent delayed arterial healing associated with first generation drug-eluting stents. However, the process of arterial healing after XIENCE-EES and SYNERGY-EES implantation has not been clarified. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28095DOI Listing
February 2019

Paravalvular leak repair after balloon-expandable transcatheter mitral valve implantation in mitral annular calcification: Early experience and lessons learned.

Catheter Cardiovasc Interv 2019 Feb 9. Epub 2019 Feb 9.

Department of Cardiovascular Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota.

Background: Treatment of hemodynamically significant mitral annular calcification (MAC) using transcatheter approaches is in the early learning phase. The occurrence of paravalvular leak (PVL) following transcatheter mitral valve in MAC is common.

Aims: To report the initial experience and techniques of percutaneous PVL closure after transcatheter valve in MAC. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ccd.28131
Publisher Site
http://dx.doi.org/10.1002/ccd.28131DOI Listing
February 2019
3 Reads

Percutaneous treatment of saphenous vein graft aneurysm: Contemporary procedural considerations.

Catheter Cardiovasc Interv 2019 Feb 9. Epub 2019 Feb 9.

Cardiovascular Department, John Hunter Hospital, Newcastle, Australia.

While coronary artery bypass grafting remains an essential component of revascularization therapy, the use of venous conduits in the form of saphenous vein grafts is associated with a number of late sequelae, including graft stenosis and occlusion. The recognition of saphenous vein graft aneurysm, typically a late complication, may be associated with adverse outcomes. We describe the percutaneous therapy of saphenous vein graft aneurysm, utilizing contemporary devices, including newer generation covered stents, and the use of devices more commonly used in peripheral vascular intervention, reflecting the dilated nature of vein grafts. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ccd.28128
Publisher Site
http://dx.doi.org/10.1002/ccd.28128DOI Listing
February 2019
4 Reads